ArticleBMC cancer2025
A qualitative exploration of patient and clinician needs and preferences for a physical activity intervention during breast cancer chemotherapy.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundEarly intervention with physical activity (PA) during active cancer treatment is critical for improved health outcomes, but often difficult to deliver. We assessed patients' and clinicians' needs and preferences for a PA intervention during chemotherapy via semi-structured interviews.
methodsWe conducted virtual semi-structured interviews from May 2022 to May 2023 with patients with stage I-III breast cancer and oncology clinicians recruited from a Midwestern comprehensive cancer center and community settings. We identified themes using deductive and inductive thematic analysis informed by the Consolidated Framework for Implementation Research.
resultsPatients (n = 16) were mostly White, non-Hispanic (93.8%) females (100%) with an average age of 56.0 ± 12.0 years. Clinicians (n = 11) were primarily medical oncologists (45%) with > 10 years of experience (54%). Participants overwhelmingly viewed PA programs as beneficial and stated that they should be integrated into standard care during chemotherapy. Participants felt that if PA programs were presented as part of treatment, patients would be more likely to engage and adhere. Regarding intervention structure, patients preferred a flexible program that allowed them to decide when and how they would complete PA. They desired remote activities to increase the convenience of the program and overcome physical and logistical barriers such as chemotherapy side effects and transportation. They also wanted some in-person group elements for social support and accountability, with individual options for patients concerned with potential disease exposure. Clinicians expressed strong support for PA programs delivered by a physical therapist with oncology training and automated referrals in the electronic health record.
conclusionsBoth patients and clinicians support PA programs delivered during chemotherapy. Key features of desirable PA programs were supervision by physical therapists, flexibility and convenience with both in-person and remote options, and group and individual components to facilitate patient participation. These findings can inform the design and implementation of future PA programs during chemotherapy for breast cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.